We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
-$1.13B
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,446
Increased
2,646
Reduced
3,048
Closed
1,267

Sector Composition

Rank Sector Weight
1 Technology 7.07%
2 Consumer Discretionary 5.88%
3 Financials 5.83%
4 Industrials 4.49%
5 Healthcare 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTR
7151
CALL
DELISTED
CytRx Corp
CYTR
$15K ﹤0.01%
5,467
+1,900
+53% +$4.81K
BLIN icon
7152
Bridgeline Digital
BLIN
$13.9M
$14K ﹤0.01%
69
-53
-43% -$9.77K
RVP icon
7153
Retractable Technologies
RVP
$20.3M
$14K ﹤0.01%
12,352
-6,940
-36% -$7.4K
OGEN icon
7154
Oragenics
OGEN
$2.39M
$13K ﹤0.01%
+2
New +$21.5K
GENE
7155
DELISTED
Genetic Technologies Ltd.
GENE
$13K ﹤0.01%
+553
New +$12.6K
CPHI icon
7156
China Pharma Holdings
CPHI
$44.2M
$12K ﹤0.01%
93
+61
+191% +$7.74K
BINI
7157
DELISTED
Bollinger Innovations
BINI
0
PLUR icon
7158
PUT
Pluri
PLUR
$17.9M
$12K ﹤0.01%
125
TMQ
7159
Trilogy Metals
TMQ
$653M
$12K ﹤0.01%
+21,417
New +$10.7K
RMGN
7160
DELISTED
RMG Networks Holding Corporation
RMGN
$12K ﹤0.01%
3,905
-3,140
-45% -$9.69K
VVUS
7161
DELISTED
Vivus Inc
VVUS
$12K ﹤0.01%
+1,093
New +$12.4K
REXX
7162
DELISTED
Rex Energy Corporation
REXX
$12K ﹤0.01%
+2,506
New +$15.1K
ITP icon
7163
IT Tech Packaging
ITP
$2.88M
$11K ﹤0.01%
1,155
-1,263
-52% -$13.9K
YTEN
7164
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$11K ﹤0.01%
3
MTL.PR
7165
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$11K ﹤0.01%
+10,401
New +$12.2K
SIFY
7166
PUT
Sify Technologies
SIFY
$1.15B
$10K ﹤0.01%
+1,833
New +$9.71K
BXE
7167
PUT
DELISTED
Bellatrix Exploration Ltd.
BXE
$10K ﹤0.01%
2,400
-480
-17% -$1.98K
ACHV icon
7168
Achieve Life Sciences
ACHV
$744M
$9K ﹤0.01%
10
-4
-29% -$4.86K
ATOS icon
7169
Atossa Therapeutics
ATOS
$25.5M
$9K ﹤0.01%
+64
New +$16.3K
CATX icon
7170
Perspective Therapeutics
CATX
$354M
$9K ﹤0.01%
1,451
-4,552
-76% -$26.6K
CDMO
7171
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$9K ﹤0.01%
1,914
-2,157
-53% -$7.23K
STAF
7172
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$9K ﹤0.01%
4
-9
-69% -$18.2K
ADGE
7173
DELISTED
American Dg Energy Inc
ADGE
$9K ﹤0.01%
28,947
-39,637
-58% -$13.2K
MEMP
7174
PUT
DELISTED
Memorial Production Partners LP Common Units
MEMP
$8K ﹤0.01%
70,200
-7,800
-10% -$1.23K
AGIG
7175
Abundia Global Impact Group
AGIG
$38.5M
$7K ﹤0.01%
+215
New +$6.23K

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors's Q1 2017 filing shows 1,446 new, 2,646 increased, 3,048 reduced and 1,267 closed positions. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M. The largest sale was Alphabet (Google) Class A, an estimated $482M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 5.3% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,446 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.